On Air Now

Listen

Listen Live Now » 101.9 FM Central Wisconsin

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
65° Feels Like: 65°
Wind: WSW 0 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Isolated Thunderstorms 85°

Tonight

Isolated Thunderstorms 61°

Tomorrow

Thundershowers 69°

Alerts

Pfizer keen to engage with AstraZeneca board

A man walks past Pfizer's world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly
A man walks past Pfizer's world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly

LONDON (Reuters) - U.S. drugmaker Pfizer kept up the pressure on bid target AstraZeneca on Tuesday, saying its offer represented compelling value for a company which would otherwise face challenges as a standalone firm.

Pfizer released a statement to set out its case for the deal, just hours before its chief executive appears in front of a British parliamentary committee to explain why he wants to acquire Britain's second largest drugmaker.

AstraZeneca has rejected a $106 billion bid from Pfizer but the U.S. group is widely expected to return with a higher offer later this week.

(Reporting by Kate Holton; Editing by Neil Maidment)

Comments